Anand Anbarasu

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 40

Top Venues

Journal of cellular biochemistry

Microbiology spectrum

3 Biotech

Medical oncology (Northwood, London, England)

VIT University

VIT University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

VIT University Jul 05 2003

India

Professor :: Biosciences

Christian Medical College Vellore Oct 01 2000 - Sep 30 2001

India

Research Officer :: Microbiology

Vignan University Oct 01 1999 - Sep 30 2000

India

Lecturer :: Microbiology

Christian Medical College Vellore Oct 01 1998 - Sep 30 1999

India

Research Officer :: Microbiology

Education History

VIT University Oct 01 2004 - Mar 27 2007

India

PHD :: Biosciences

Christian Medical College Vellore Jul 01 1995 - Sep 30 1998

India

MSC :: Microbiology

University of Madras Aug 01 1992 - May 18 1995

India

BSC :: Microbiology

Publications

Aditi Roy, Rayapadi G Swetha, Soumya Basu, Rhitam Biswas, Sudha Ramaiah, Anand Anbarasu
Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1. 3 Biotech 14 (7) (2024)
Soumya Basu, Gayathri Ashok, Soumyadip Ghosh, Sudha Ramaiah, Veeraraghavan Balaji, Anand Anbarasu
Cefiderocol susceptibility endows hope in treating carbapenem-resistant Pseudomonas aeruginosa : insights from in vitro and in silico evidence. RSC advances 14 (30) (2024)
Soumya Basu, Gayathri Ashok, Soumyadip Ghosh, Sudha Ramaiah, Veeraraghavan Balaji, Anand Anbarasu
Cefiderocol susceptibility endows hope in treating carbapenem-resistant Pseudomonas aeruginosa : insights from in vitro and in silico evidence. RSC advances 14 (30) (2024)
Avani Panickar, Anand Manoharan, Anand Anbarasu, Sudha Ramaiah
Respiratory tract infections: an update on the complexity of bacterial diversity, therapeutic interventions and breakthroughs. Archives of microbiology 206 (9) (2024)
Hithesh Kumar, Anand Manoharan, Anand Anbarasu, Sudha Ramaiah
Computational study of the piperidine and FtsZ interaction in Salmonella Typhi: implications for disrupting cell division machinery. Journal of biomolecular structure & dynamics (2024)
Saranya Vijayakumar, Rayapadi G Swetha, Yamuna Devi Bakthavatchalam, Karthick Vasudevan, Baby Abirami Shankar, Agilandeeswari Kirubananthan, Kamini Walia, Sudha Ramaiah, Indranil Biswas, Veeraraghavan Balaji, Anand Anbarasu
Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. Microbiology spectrum 12 (2) (2024)
Tushar Joshi, Santhiya Vijayakumar, Soumyadip Ghosh, Shalini Mathpal, Sudha Ramaiah, Anand Anbarasu
Identifying Novel Therapeutics for the Resistant Mutant "F533L" in PBP3 of Pseudomonas aeruginosa Using ML Techniques. ACS omega 9 (26) (2024)
Santhiya Vijayakumar, Hithesh Kumar, Soumya Basu, Sara Chandy, Anand Anbarasu, Anand Manoharan, Sudha Ramaiah
Changing Landscape of Antimicrobial Resistance in Neonatal Sepsis: An in silico Analyses of Multidrug Resistance in Klebsiella pneumoniae. The Pediatric infectious disease journal (2024)
Santhiya Vijayakumar, Hithesh Kumar, Soumya Basu, Sara Chandy, Anand Anbarasu, Anand Manoharan, Sudha Ramaiah
Changing Landscape of Antimicrobial Resistance in Neonatal Sepsis: An in silico Analyses of Multidrug Resistance in Klebsiella pneumoniae. The Pediatric infectious disease journal 43 (8) (2024)
Aditi Roy, Rayapadi G Swetha, Soumya Basu, Rhitam Biswas, Sudha Ramaiah, Anand Anbarasu
Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1. 3 Biotech 14 (7) (2024)
Aditi Roy, Rayapadi G Swetha, Soumya Basu, Rhitam Biswas, Sudha Ramaiah, Anand Anbarasu
Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1. 3 Biotech 14 (7) (2024)
Saranya Vijayakumar, Rayapadi G Swetha, Yamuna Devi Bakthavatchalam, Karthick Vasudevan, Baby Abirami Shankar, Agilandeeswari Kirubananthan, Kamini Walia, Sudha Ramaiah, Indranil Biswas, Veeraraghavan Balaji, Anand Anbarasu
Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. Microbiology spectrum 12 (2) (2024)
Saranya Vijayakumar, Rayapadi G Swetha, Yamuna Devi Bakthavatchalam, Karthick Vasudevan, Baby Abirami Shankar, Agilandeeswari Kirubananthan, Kamini Walia, Sudha Ramaiah, Indranil Biswas, Veeraraghavan Balaji, Anand Anbarasu
Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. Microbiology spectrum (2024)
Saranya Vijayakumar, Rayapadi G Swetha, Yamuna Devi Bakthavatchalam, Karthick Vasudevan, Baby Abirami Shankar, Agilandeeswari Kirubananthan, Kamini Walia, Sudha Ramaiah, Indranil Biswas, Veeraraghavan Balaji, Anand Anbarasu
Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. Microbiology spectrum 12 (2) (2024)
Tushar Joshi, Santhiya Vijayakumar, Soumyadip Ghosh, Shalini Mathpal, Sudha Ramaiah, Anand Anbarasu
Identifying Novel Therapeutics for the Resistant Mutant "F533L" in PBP3 of Pseudomonas aeruginosa Using ML Techniques. ACS omega 9 (26) (2024)
Aditi Roy, Rayapadi G Swetha, Soumya Basu, Rhitam Biswas, Sudha Ramaiah, Anand Anbarasu
Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1. 3 Biotech 14 (7) (2024)
Gayathri Ashok, Soumya Basu, Priyamvada Priyamvada, Anand Anbarasu, Sreenivasulu Chintala, Sudha Ramaiah
Coinfections in human papillomavirus associated cancers and prophylactic recommendations. Reviews in medical virology 34 (2) (2024)
Sreenivasulu Chintala, Maura A Dankoski, Anand Anbarasu, Sudha Ramaiah, Sravan Kumar Miryala, Rachel A Katzenellenbogen
NFX1-123: A potential therapeutic target in cervical cancer. Journal of medical virology 95 (6) (2023)
Suvitha Anbarasu, Anand Anbarasu
Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review. Medical oncology (Northwood, London, England) 40 (6) (2023)
Gayathri Ashok, Abirami Soundararajan, Anand Anbarasu, Sudha Ramaiah
Elucidating the molecular role of MUC5B in progressive lung adenocarcinoma: Prospects for early diagnosis. Journal of molecular recognition : JMR (2023)
Suvitha Anbarasu, Anand Anbarasu
Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review. Medical oncology (Northwood, London, England) 40 (6) (2023)
Soumya Basu, Balaji Veeraraghavan, Anand Anbarasu
Impact of PmrB mutations on clinical Klebsiella pneumoniae with variable colistin-susceptibilities: Structural insights and potent therapeutic solutions. Chemical biology & drug design (2023)
Soumya Basu, Gayathri Ashok, Reetika Debroy, Sudha Ramaiah, Paul G Livingstone, Anand Anbarasu
Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective. Human vaccines & immunotherapeutics (2023)
Sreeram Chandra Murthy Peela, Soumya Basu, Jyoti Sharma, Abdullah F AlAsmari, Fawaz AlAsmari, Sultan Alalmaee, Sudha Ramaiah, Sujatha Sistla, Paul Livingstone, Anand Anbarasu
Structure Elucidation and Interaction Dynamics of MefA-MsrD Efflux Proteins in Streptococcus pneumoniae : Impact on Macrolide Susceptibility. ACS omega 8 (42) (2023)
Suvitha Anbarasu, Anand Anbarasu
Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review. Medical oncology (Northwood, London, England) 40 (6) (2023)
Gayathri Ashok, Rohini Das, Anand Anbarasu, Sudha Ramaiah
Comprehensive analysis on the diagnostic role of circulatory exosome-based miR-92a-3p for osteoblastic metastases in prostate adenocarcinoma. Journal of molecular recognition : JMR (2023)
Soumya Basu, Sahil Mandar Joshi, Sudha Ramaiah, Anand Anbarasu
Designing Anti-Microbial Peptides Against Major β-Lactamase Enzymes in Clinically Important Gram-Negative Bacterial Pathogens: An In-Silico Study. Probiotics and antimicrobial proteins 14 (2) (2022)
Priyamvada Priyamvada, Reetika Debroy, Anand Anbarasu, Sudha Ramaiah
A comprehensive review on genomics, systems biology and structural biology approaches for combating antimicrobial resistance in ESKAPE pathogens: computational tools and recent advancements. World journal of microbiology & biotechnology 38 (9) (2022)
Soumya Basu, Reetika Debroy, Hithesh Kumar, Harpreet Singh, Sudha Ramaiah, Anand Anbarasu
Bioactive phytocompounds against specific target proteins of Borrelia recurrentis responsible for louse-borne relapsing fever: Genomics and structural bioinformatics evidence. Medical and veterinary entomology (2022)
Gayathri Ashok, Sravan Kumar Miryala, Megha Treesa Saju, Anand Anbarasu, Sudha Ramaiah
FN1 encoding fibronectin as a pivotal signaling gene for therapeutic intervention against pancreatic cancer. Molecular genetics and genomics : MGG 297 (6) (2022)
Aniket Naha, Saranya Vijayakumar, Binesh Lal, Baby A Shankar, Suriya Chandran, Sudha Ramaiah, Veeraraghavan Balaji, Anand Anbarasu
Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of sulbactam-durlobactam holds promise for therapeutic intervention. Journal of cellular biochemistry 122 (12) (2021)
Soumya Basu, Aniket Naha, Veeraraghavan Balaji, Sudha Ramaiah, Anand Anbarasu
In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis. Journal of cellular biochemistry (2021)
Soumya Basu, Sudha Ramaiah, Anand Anbarasu
In-silico strategies to combat COVID-19: A comprehensive review. Biotechnology & genetic engineering reviews 37 (1) (2021)
Sravan Kumar Miryala, Anand Anbarasu, Sudha Ramaiah
Gene interaction network approach to elucidate the multidrug resistance mechanisms in the pathogenic bacterial strain Proteus mirabilis. Journal of cellular physiology 236 (1) (2020)
Anand Anbarasu, Sudha Ramaiah, Paul Livingstone
Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality? Human vaccines & immunotherapeutics 16 (9) (2020)
Kullappan Malathi, Sudha Ramaiah, Anand Anbarasu
Comparative Molecular Field Analysis and Molecular Docking Studies on Quinolinone Derivatives Indicate Potential Hepatitis C Virus Inhibitors. Cell biochemistry and biophysics 77 (2) (2019)
Sravan Kumar Miryala, Anand Anbarasu, Sudha Ramaiah
Impact of bedaquiline and capreomycin on the gene expression patterns of multidrug-resistant Mycobacterium tuberculosis H37Rv strain and understanding the molecular mechanism of antibiotic resistance. Journal of cellular biochemistry 120 (9) (2019)
Adhithya Ragunathan, Kullappan Malathi, Sudha Ramaiah, Anand Anbarasu
FtsA as a cidal target for Staphylococcus aureus: Molecular docking and dynamics studies. Journal of cellular biochemistry (2018)
Adhithya Ragunathan, Kullappan Malathi, Anand Anbarasu
MurB as a target in an alternative approach to tackle the Vibrio cholerae resistance using molecular docking and simulation study. Journal of cellular biochemistry 119 (2) (2017)
Rayapadi G Swetha, Sudha Ramaiah, Anand Anbarasu, Kanagaraj Sekar
Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses. Advances in bioinformatics 2016 (2016)
Chundi Vinay Kumar, Rayapadi G Swetha, Anand Anbarasu, Sudha Ramaiah
Computational Analysis Reveals the Association of Threonine 118 Methionine Mutation in PMP22 Resulting in CMT-1A. Advances in bioinformatics 2014 (2014)

Anand Anbarasu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anand Anbarasu